Where Are the Best Cannabis Investment Opportunities in New York?
Legal marijuana in the Empire State has all the inevitability of gravity at this point, so it’s never been a better time to consider winning cannabis investment opportunities in New York. Legislative efforts at legalization had the wind knocked out of them in 2020 by the pandemic and the extraordinary measures the New York legislature (and the state at large) had to undergo as a result. However, there is still a great deal of political will supporting the procedure, not least from Governor Andrew Cuomo. Cannabis Growth Fund monitors the expansion of the cannabis industry in New York state, the better to manage our industry-focused mutual fund.
Opportunities that Hinge on New York Marijuana Legalization
At present, the medical cannabis program in New York is expanding steadily. Between January and December 2019, the number of medical marijuana patients in the state rose from 88 thousand to 111 thousand. However, compared to other states, uptake is low. In spite of perks like home delivery, less than 1% of New York residents are medical marijuana patients, while 6.3% of Oklahomans have registered. Given that New York’s qualifying condition list is robust, and that in 2017 New Yorkers smoked more cannabis than any other city in the world, an explanation for this low uptake may be that the majority of cannabis-consuming New York state residents are sourcing their cannabis products from the black market. The tax revenue lost from this huge market is itself reason for the state to legalize cannabis sales and profit from the legal market.
Cannabis Growth Fund allows investors to take a broad-spread approach to cannabis investment. Our actively managed mutual fund focuses primarily on companies related to the cannabis industry. We are an alternative to spending hours poring over industry periodicals for which individual stocks to buy. If you’re interested in investing with us, you can enquire through our website.
Foothill Capital Management is the advisor of the Cannabis Growth Fund and is not affiliated with the distributor.
OF SPECIAL NOTE
Statements, estimates and forecasts are subject to significant legal, business, economic, and competitive uncertainties, including competition, limited access to bank services, litigation, enforcement actions, and the receipt of government authorizations. This includes differences in, among other things, laws, regulations and guidelines relating to the manufacture, transportation, and storage of cannabis, and the conduct of operations, which vary among the U.S. federal government, various states, and foreign jurisdictions. There can no assurance that such estimates and/or forecasts will be realized, and these are not indicative of future investment performance. Historical data is not indicative of future performance.
Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus, a copy of which may be obtained from 888.885.0588 or at https://www.cannabisgrowthfunds.com/. Please read the prospectus carefully before you invest.
Investing involves risk, including possible loss of principal. The cannabis industry is subject to rapidly evolving laws, rules and regulations, and increasing competition which may cause such companies to change business model, shrink or suddenly close. These may limit access to banks, and create significant burdens on company resources due to litigation, enforcement actions, receipt of necessary permits and authorizations to engage in medical cannabis research or to otherwise cultivate, possess or distribute cannabis. Possession and use of cannabis is illegal under federal and certain states’ laws, which may negatively impact the value of Fund investments. Where legalized by states, cannabis possession and use remains a violation of federal law. The companies in which the Fund invests are subject to various laws and regulations relating to the manufacture, management, transportation, storage and disposal of cannabis, including health and safety, conduct of operations, and environmental protection. Even if a company’s operations are permitted under current law, they may not be permitted in the future, and a company may not be able to continue operations in its current location. Controlled substance legislation differs significantly between countries and may limit a company’s ability to sell products.
Foreign investing involves social and political instability, market illiquidity, exchange-rate fluctuation, high volatility and limited regulation risks. Emerging markets involve different and greater risks, as they are smaller, less liquid and more volatile than more developed countries. Investments made in small, mid-capitalization and micro-capitalization companies may be more volatile and less liquid due to limited resources or product lines and more sensitive to economic factors. Fund investments will be concentrated in an industry or group of industries, and the value of Fund shares may rise and fall more than more diversified funds. Purchasing and writing put and call options entails greater than ordinary investment risks. Options ownership involves the payment of premiums, which may negatively impact Fund performance. Please see the prospectus for details of these and other risks. Distributed by IMST Distributors, LLC.